Search results for devices

Markets | premium series motorola portable devices All

Stocks | sandisk ducati edition memory – – camera camcorder mobile phones gaming devices – sdsdpx3-004g-ad1 – All

Stocks | market recap stocks seesawed flat line finish slightly red light trading telecom stocks rose obama signed memorandum raising spectrum smartphones wireless internet devices consumer staples boost supreme court rejected government appeal tobacco case nyse decliners outnumbered advancers two All

Stocks | Of the 11 Health Trend Stock Indexes that I have created revised and tracked over the past few years that are now being tracked at the Investars YOU website the actively managed Emerging Cancer Diagnostic & Therapeutic (Dx / Tx) Index is the top performer. The Investars site includes automated index tracking and allows investors to link their brokerage accounts to create custom stock portfolios based on their individual preferences from the stock indexes at the site. The site also allows unregistered users to generate stock ideas from my indexes since I allow free access to my content. <o:p> </o:p>

<o:p>   </o:p>

Follow these steps in order to generate stock ideas from any of my indexes at the site: 1) Click 'Add to You' at top third of page at left column; 2) Choose the front/center option (in white inside a divided circle) to add all of the index stocks to your portfolio; 3) Click 'expand section' at lower/right column of page that appears with the stocks generated from the index that was originally chosen which are sorted alphabetically. <o:p> </o:p>

<o:p>   </o:p>

The constituents of the Emerging Cancer Dx / Tx index ( click to enlarge images at original article on my personal blog site ) reflect a cross-section of emerging cancer companies with market caps below $500 million at the time of index inclusion encompassing the following categories: (1) diagnostics (molecular diagnostics and device-based diagnostics) (2) lab services (personalized medicine applications to guide and track the effectiveness of cancer treatments) (3) drug discovery (screening and modifying compounds to achieve anti-cancer effects during the early stages of preclinical and Phase 1 clinical studies) (4) immunotherapy (a.k.a. cancer vaccines which are designed to stimulate the immune system to eradicate cancer) and (5) commercial or late-stage (Phase 2-3) clinical development therapeutics devices or diagnostics intended for use by cancer patients. <o:p> </o:p>

<o:p>   </o:p>

http://www.mikehavrx.com/2009/09/emerging-cancer-stocks-lead-... <o:p> </o:p>

<o:p>   </o:p>

Many of the stocks that I own and which are included in my coverage universe ( upper right column of any page at MikeHavRx.com ) are components of this index such as Access Pharma (OTC: ACCP.OB) CombiMatrix (NASDAQ: CBMX) Delcath Systems (NASDAQ: DCTH) EXACT Sciences (NASDAQ: EXAS) ImmunoCellular (OTC: IMUC.OB) Lixte Biotech (OTC: LIXT.OB) and YM BioSciences (AMEX: YMI) in addition to one privately-held company that is developing a cancer vaccine that targets a universal cancer antigen (OFA) Quantum Immunologics. <o:p> </o:p>

<o:p>   </o:p>

Disclosure: Long ACCP.OB CBMX EXAS IMUC.OB <o:p> </o:p>

<o:p>   </o:p>

See my full disclaimer at MikeHavRx.com (bottom of any page). <o:p> </o:p>

All

Stocks | analog devices adi sees fq eps vs consensus sees revenue vs q weak demand inventory reductions shares ah pr All

Stocks | the time paytoenablefeatures devices All